Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Study of TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer

NCT01282151 is registered in ClinicalTrials.gov with Chonnam National University Hospital as lead sponsor.

NCT NCT01282151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01282151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Study of TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer
Lead sponsor
Chonnam National University Hospital
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 2011
Completion date
December 31, 2014
Enrollment
148 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non small cell lung